Literature DB >> 10441042

Glycemic control and cardiovascular disease in type 2 diabetes: a review.

S H Wild1, C J Dunn, P M McKeigue, S Comte.   

Abstract

Cardiovascular disease is the major cause of morbidity and mortality in people with Type 2 diabetes, and risk of atherosclerotic disease is markedly increased in people with diabetes compared to people with normal glucose tolerance. The excess risk can not be completely explained by increased prevalence of other cardiovascular disease risk factors such as hypertension and hyperlipidaemia in people with diabetes. This review examines the role of hyperglycemia and glycemic control in cardiovascular disease in people with Type 2 diabetes. The results of prospective observational studies and randomized controlled trials are summarized. We conclude that control of hypertension and hyperlipidemia are important to reduce risk of cardiovascular disease in people with diabetes and may be more easily achieved than tight glycemic control. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  1999        PMID: 10441042     DOI: 10.1002/(sici)1520-7560(199905/06)15:3<197::aid-dmrr28>3.0.co;2-f

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  6 in total

1.  Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes.

Authors:  Y Shimoni
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

Review 2.  Multifactorial intervention to reduce cardiovascular events in type 2 diabetes.

Authors:  Swapnil N Rajpathak; Vikas Aggarwal; Frank B Hu
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

3.  Sex differences in the modulation of K+ currents in diabetic rat cardiac myocytes.

Authors:  Yakhin Shimoni; Xiu-Fang Liu
Journal:  J Physiol       Date:  2003-05-30       Impact factor: 5.182

4.  Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes.

Authors:  Alessandro Doria; Joanna Wojcik; Rui Xu; Ernest V Gervino; Thomas H Hauser; Michael T Johnstone; David Nolan; Frank B Hu; James H Warram
Journal:  JAMA       Date:  2008-11-26       Impact factor: 56.272

5.  Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake.

Authors:  Jan Bucerius; Venkatesh Mani; Colin Moncrieff; James H F Rudd; Josef Machac; Valentin Fuster; Michael E Farkouh; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2012-06-05       Impact factor: 24.094

6.  Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis.

Authors:  John Peter Mitsios; Elif Ilhan Ekinci; Gregory Peter Mitsios; Leonid Churilov; Vincent Thijs
Journal:  J Am Heart Assoc       Date:  2018-05-17       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.